Request Trial
5 September 2024FeaturesUnified Patent CourtEmily Bottle, Sebastian Moore

Does the UPC offer a fresh take on patent validity?

A distinctive UPC approach to patent validity and revocations is emerging as the court shows its willingness to break new ground, say Emily Bottle and Sebastian Moore of HSF.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025   Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.
Unified Patent Court
'A very good decision’: Patent industry welcomes UPC in-house reps update
13 February 2025   Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v Suinno Mobile & AI Technologies Licensing.


Editor's picks

Bayer enters COVID-19 vaccine row with three suits against major drugmakers
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026

Editor's picks

Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Insulin pump rivals face off in major trade secrets dispute hearing
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
Arnold & Porter loses another regulatory partner to growing rival
CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’
Novo Nordisk secures China win ahead of key patent expiration
Edwards v Meril: Inside the UPC’s landmark medtech showdown
Bird & Bird targets Nordic life sciences growth with regulatory hire